Severe upper extremity dysfunction after 4CMenB vaccination in a young infant

The 4-component meningococcal serogroup B vaccine 4CMenB (Bexsero) is the first vaccine against this serogroup and has been approved by licensing authorities in Europe, Canada and Australia. Therefore, the vaccine may enter soon nationwide vaccine recommendation schemes. We report on a case of a 5-m...

Full description

Saved in:
Bibliographic Details
Main Authors: Tenenbaum, Tobias (Author) , Niessen, Johanna (Author) , Schroten, Horst (Author)
Format: Article (Journal)
Language:English
Published: January 2016
In: The pediatric infectious disease journal
Year: 2016, Volume: 35, Issue: 1, Pages: 94-96
ISSN:1532-0987
Online Access: Get full text
Author Notes:Tobias Tenenbaum, MD, Johanna Niessen, MD, and Horst Schroten, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1587790734
003 DE-627
005 20230427034241.0
007 cr uuu---uuuuu
008 190219s2016 xx |||||o 00| ||eng c
024 7 |a 10.1097/INF.0000000000000917  |2 doi 
035 |a (DE-627)1587790734 
035 |a (DE-576)517790734 
035 |a (DE-599)BSZ517790734 
035 |a (OCoLC)1341038315 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tenenbaum, Tobias  |d 1973-  |e VerfasserIn  |0 (DE-588)128399155  |0 (DE-627)372640109  |0 (DE-576)302559752  |4 aut 
245 1 0 |a Severe upper extremity dysfunction after 4CMenB vaccination in a young infant  |c Tobias Tenenbaum, MD, Johanna Niessen, MD, and Horst Schroten, MD 
264 1 |c January 2016 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.02.2019 
520 |a The 4-component meningococcal serogroup B vaccine 4CMenB (Bexsero) is the first vaccine against this serogroup and has been approved by licensing authorities in Europe, Canada and Australia. Therefore, the vaccine may enter soon nationwide vaccine recommendation schemes. We report on a case of a 5-month-old infant who developed prolonged upper extremity dysfunction after the second injection of the 4CMenB vaccine in the left deltoid muscle and was concomitantly applied with 2 routine vaccinations. Myositis, periostitis, (peri-) vasculitis and axillary inflammation were confirmed by magnetic resonance imaging. Two months after initial initiation of an anti-inflammatory and an antibiotic treatment, symptoms completely resolved. Administration of 3 vaccines requires clear recommendations for the preferred injection site in infants because increased reactogenicity of 4CMenB may lead to local severe adverse events. 
650 4 |a adverse events 
650 4 |a children 
650 4 |a meningococcal B vaccine 
650 4 |a Neisseria meningitidis 
650 4 |a reactogenicity 
700 1 |a Niessen, Johanna  |e VerfasserIn  |0 (DE-588)1178461165  |0 (DE-627)1049389395  |0 (DE-576)51779036X  |4 aut 
700 1 |a Schroten, Horst  |d 1957-  |e VerfasserIn  |0 (DE-588)1031228837  |0 (DE-627)736021612  |0 (DE-576)378668226  |4 aut 
773 0 8 |i Enthalten in  |t The pediatric infectious disease journal  |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1987  |g 35(2016), 1, Seite 94-96  |h Online-Ressource  |w (DE-627)320601382  |w (DE-600)2020216-7  |w (DE-576)094400547  |x 1532-0987  |7 nnas  |a Severe upper extremity dysfunction after 4CMenB vaccination in a young infant 
773 1 8 |g volume:35  |g year:2016  |g number:1  |g pages:94-96  |g extent:3  |a Severe upper extremity dysfunction after 4CMenB vaccination in a young infant 
951 |a AR 
992 |a 20190219 
993 |a Article 
994 |a 2016 
998 |g 1031228837  |a Schroten, Horst  |m 1031228837:Schroten, Horst  |d 60000  |d 62300  |e 60000PS1031228837  |e 62300PS1031228837  |k 0/60000/  |k 1/60000/62300/  |p 3  |y j 
998 |g 128399155  |a Tenenbaum, Tobias  |m 128399155:Tenenbaum, Tobias  |d 60000  |d 62300  |e 60000PT128399155  |e 62300PT128399155  |k 0/60000/  |k 1/60000/62300/  |p 1  |x j 
999 |a KXP-PPN1587790734  |e 3056189853 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 19.02.2019"],"language":["eng"],"relHost":[{"pubHistory":["6.1987 -"],"language":["eng"],"disp":"Severe upper extremity dysfunction after 4CMenB vaccination in a young infantThe pediatric infectious disease journal","title":[{"subtitle":"PIDJ ; an official publication of The Pediatric Infectious Diseases Society and the European Society for Paediatric Infectious Diseases","title":"The pediatric infectious disease journal","title_sort":"pediatric infectious disease journal"}],"origin":[{"publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1987","publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1987-"}],"id":{"issn":["1532-0987"],"eki":["320601382"],"zdb":["2020216-7"]},"part":{"issue":"1","volume":"35","extent":"3","text":"35(2016), 1, Seite 94-96","year":"2016","pages":"94-96"},"note":["Gesehen am 18.01.2022"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"320601382","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"PIDJ"}]}],"recId":"1587790734","physDesc":[{"extent":"3 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Tobias Tenenbaum, MD, Johanna Niessen, MD, and Horst Schroten, MD"]},"title":[{"title":"Severe upper extremity dysfunction after 4CMenB vaccination in a young infant","title_sort":"Severe upper extremity dysfunction after 4CMenB vaccination in a young infant"}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"January 2016"}],"person":[{"family":"Tenenbaum","role":"aut","display":"Tenenbaum, Tobias","given":"Tobias"},{"given":"Johanna","family":"Niessen","role":"aut","display":"Niessen, Johanna"},{"role":"aut","display":"Schroten, Horst","family":"Schroten","given":"Horst"}],"id":{"eki":["1587790734"],"doi":["10.1097/INF.0000000000000917"]}} 
SRT |a TENENBAUMTSEVEREUPPE2016